Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA).
Burmester GR, Rubbert-Roth A, Cantagrel A, Hall S, Leszczynski P, Feldman D, Rangaraj MJ, Roane G, Ludivico C, Bao M, Rowell L, Davies C, Mysler EF. Burmester GR, et al. Among authors: feldman d. Ann Rheum Dis. 2016 Jan;75(1):68-74. doi: 10.1136/annrheumdis-2015-207281. Epub 2015 Jun 8. Ann Rheum Dis. 2016. PMID: 26056119 Free PMC article. Clinical Trial.
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
Burmester GR, Rubbert-Roth A, Cantagrel A, Hall S, Leszczynski P, Feldman D, Rangaraj MJ, Roane G, Ludivico C, Lu P, Rowell L, Bao M, Mysler EF. Burmester GR, et al. Among authors: feldman d. Ann Rheum Dis. 2014 Jan;73(1):69-74. doi: 10.1136/annrheumdis-2013-203523. Epub 2013 Jul 31. Ann Rheum Dis. 2014. PMID: 23904473 Free PMC article. Clinical Trial.
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.
Fitzgerald KN, Lee CH, Voss MH, Carlo MI, Knezevic A, Peralta L, Chen Y, Lefkowitz RA, Shah NJ, Owens CN, McHugh DJ, Aggen DH, Laccetti AL, Kotecha RR, Feldman DR, Motzer RJ. Fitzgerald KN, et al. Among authors: feldman dr. Eur Urol. 2024 May 22:S0302-2838(24)02349-2. doi: 10.1016/j.eururo.2024.04.025. Online ahead of print. Eur Urol. 2024. PMID: 38782695
State rumination predicts inhibitory control failures and dysregulation of default, salience, and cognitive control networks in youth at risk of depressive relapse: Findings from the RuMeChange trial.
Roberts H, Schreiner MW, Pocius S, Dillahunt AK, Farstead B, Feldman D, Bessette KL, Kaufman EA, Slattery W, Jacobs RH, Jago D, Crowell SE, Watkins ER, Langenecker SA. Roberts H, et al. Among authors: feldman d. J Affect Disord Rep. 2024 Apr;16:100729. doi: 10.1016/j.jadr.2024.100729. Epub 2024 Jan 10. J Affect Disord Rep. 2024. PMID: 38769946 Free PMC article.
Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019).
Vohra AS, Olonoff DA, Ip A, Kirtane AJ, Steinberg Z, Horn E, Krishnan U, Reisman M, Bergman G, Wong SC, Feldman DN, Kim LK, Singh HS. Vohra AS, et al. Among authors: feldman dn. Pulm Circ. 2024 May 9;14(2):e12374. doi: 10.1002/pul2.12374. eCollection 2024 Apr. Pulm Circ. 2024. PMID: 38736894 Free PMC article.
The Importance of Hope for Patients With CKD.
Feldman DL, Fuller LJ. Feldman DL, et al. Am J Kidney Dis. 2024 Apr 26:S0272-6386(24)00680-2. doi: 10.1053/j.ajkd.2024.01.531. Online ahead of print. Am J Kidney Dis. 2024. PMID: 38678459 No abstract available.
1,873 results